Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SnowShredder who wrote (7830)	2/6/2003 10:53:15 AM
From: Biomaven	Read Replies (1) of 52153

Interesting price performance by CEPH the last two days: finance.yahoo.com This has come amidst yesterday's announcement after the close of the filing of a generic challenge to Provigil. Not sure of the explanation for the strength. The filing (albeit not the exact timing) was widely expected, so maybe we are seeing short covering today when the stock showed resilience. There was also a carefully-timed upgrade by MS. I remain long, albeit with a modest position. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next